Gregory Berk

Gregory Berk (board member) discloses dealings in 2 companies, chiefly GT Biopharma, Inc. and Hana Biosciences Inc. Between 9 May 2006 and 16 February 2021, the trades on record add up to 2 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The record was last updated on 14 February 2022 with a share grant in GT Biopharma, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.